Stockholm, February 20 2013 — NASDAQ OMX (NASDAQ: NDAQ) announces that the trading in Cell Impact AB (short name: CI B) shares will commence today on First North at NASDAQ OMX Stockholm. Cell Impact, a spin-off company from Amasten (previously Morphic Technologies), belongs to the Industrial sector and is the fourth new company to be admitted to trading on First North in 2013.
Cell Impact develops and markets high velocity impact units – a patented and innovative technology that acts to create a more sustainable society. The technology can be used to shape and shear material by using high kinetic energy, thus providing new opportunities in terms of improved quality for a wide area of applications.
“At First North we expect to gain increased exposure for our innovative solutions by reaching out to a wider investor audience,” said Cell Impact’s CEO Mats Wallin. “Cell Impact operates in a market with tremendous potential and we look forward to leveraging our publicly traded status in order to build our brand and support continued financial growth.”
“We are pleased to welcome Cell Impact to First North and NASDAQ OMX’s world-leading industrials sector,” said Emelie Jarnesten, head of NASDAQ OMX First North. “It is encouraging to see a continued strong inflow of companies to our First North market and we welcome more companies to take advantage of the investor visibility and reach that we can offer.”
Cell Impact has appointed Mangold Fondkommission AB as Certified Adviser.
- # -
About First North
First North is regulated as a multilateral trading facility, operated by the different exchanges within NASDAQ OMX Nordic. It does not have the legal status as an EU-regulated market. Companies at First North are subject to the rules of First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.
About NASDAQ OMX
The inventor of the electronic exchange, The NASDAQ OMX Group, Inc., fuels economies and provides transformative technologies for the entire lifecycle of a trade - from risk management to trade to surveillance to clearing. In the U.S. and Europe, we own and operate 26 markets including 3 clearinghouses and 5 central securities depositories supporting equities, options, fixed income, derivatives, commodities, futures and structured products. Able to process more than 1 million messages per second at sub-55 microsecond average speeds with 99.99% uptime, our technology drives more than 70 marketplaces in 50 developed and emerging countries into the future, powering 1 in 10 of the world’s securities transactions. Our award-winning data products and worldwide indexes are the benchmarks in the financial industry. Home to approximately 3,300 listed companies worth $6 trillion in market cap whose innovations shape our world, we give the ideas of tomorrow access to capital today. Welcome to where the world takes a big leap forward, daily. Welcome to the NASDAQ OMX Century.
To learn more, visit http://www.nasdaqomx.com. Follow us on Facebook (http://www.facebook.com/nasdaqomx) and Twitter (http://www.twitter.com/nasdaqomx). (Symbol: NDAQ and member of S&P 500)
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about NASDAQ OMX's products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond NASDAQ OMX's control. These factors include, but are not limited to factors detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
Media contact:
Martin Hedensiö
+46 8 405 62 54
